HealthEquity (FRA:2HE) Shares Outstanding (EOP): 84 Mil (As of Apr. 2026)


FRA:2HE HealthEquity Inc FRA:2HE
93 GF Score
Price €83.00
GF Value €89.81
! 3 Warning Signs
View Full Analysis

What is HealthEquity Shares Outstanding (EOP)?

HealthEquity FRA:2HE +3.75% 93 Shares Outstanding (EOP) is 84 Mil as of Apr. 2026. GuruFocus rates FRA:2HE with a GF Score™ of 93/100 and a GF Value™ of €89.81. The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. HealthEquity's shares outstanding for the quarter that ended in Apr. 2026 was 84 Mil.

HealthEquity's quarterly shares outstanding declined from Jan. 2026 (85 Mil) to Apr. 2026 (84 Mil). It means HealthEquity bought back shares from Jan. 2026 to Apr. 2026 .

HealthEquity's annual shares outstanding declined from Jan. 2025 (87 Mil) to Jan. 2026 (85 Mil). It means HealthEquity bought back shares from Jan. 2025 to Jan. 2026 .


HealthEquity  (FRA:2HE) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


HealthEquity Shares Outstanding (EOP) Related Terms


HealthEquity Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for HealthEquity's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity Shares Outstanding (EOP) Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.78 84.76 86.13 86.54 85.01

HealthEquity Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.71 86.42 85.62 85.01 83.93

FRA:2HE vs HNGE, TEM, TXG: Shares Outstanding (EOP) Comparison

For the Health Information Services subindustry, HealthEquity's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where HealthEquity's Shares Outstanding (EOP) falls into.


FRA:2HE
93GF Score
HealthEquity Inc FRA:2HE
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 84 Mil mean?
HealthEquity (FRA:2HE) has a Shares Outstanding (EOP) of 84 Mil as of Apr. 2026. The total shares a company has outstanding, at period-end. View historical data on HealthEquity and its competitors.
Is HealthEquity's Shares Outstanding (EOP) too high?
HealthEquity's current Shares Outstanding (EOP) is 84 Mil. Overall, HealthEquity has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Shares Outstanding (EOP) compare to HNGE and TEM?
HealthEquity's Shares Outstanding (EOP) of 84 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on HealthEquity and its competitors. HealthEquity's current Shares Outstanding (EOP) is 84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Shares Outstanding (EOP) of 84 Mil. The stock's GF Value™ is €89.81, compared to a current price of €83.00 — trading 7.6% below its estimated fair value. The current Shares Outstanding (EOP) is 84 Mil. HealthEquity's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Shares Outstanding (EOP) is 84 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €83.00 is trading 7.6% below its estimated GF Value™ of €89.81.

Key valuation signals for FRA:2HE:

  • Shares Outstanding (EOP): 84 Mil
  • GF Value™: €89.81 vs. price of €83.00 (7.6% below fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
93GF Score

Get the complete analysis for FRA:2HE

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€83.00
Price
€89.81
GF Value